MedPath

VIIV HEALTHCARE COMPANY

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:1
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

16

FDA:16

Drug Approvals

Rukobia

Approval Date
Feb 13, 2024
FDA

Cabenuva

Approval Date
Dec 13, 2023
FDA

Apretude

Approval Date
Dec 13, 2023
FDA

Vocabria

Approval Date
Dec 13, 2023
FDA

Dovato

Approval Date
Nov 3, 2023
FDA

ZIAGEN

Approval Date
Sep 29, 2023
FDA

COMBIVIR

Approval Date
Aug 22, 2023
FDA

Triumeq

Approval Date
Jun 15, 2023
FDA

RETROVIR

Approval Date
Jun 15, 2023
FDA

EPZICOM

Approval Date
Dec 14, 2022
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.